Explore how Bachem oligonucleotide production works, from synthesis and scale-up to quality control, and what buyers should ask before choosing a CDMO partner.
Bachem oligonucleotide services cover custom synthesis and contract manufacturing of short DNA and RNA strands, including antisense, siRNA, and diagnostic sequences. Bachem AG is a Swiss peptide and oligonucleotide CDMO that produces these molecules for pharmaceutical and biotech clients rather than selling them to consumers. If you are evaluating Bachem as an oligonucleotide supplier, the four variables that matter most are scale, grade, documentation, and timeline.
What Bachem's Oligonucleotide Business Covers
Oligonucleotides are short chains of nucleotides, usually somewhere between 15 and 50 bases. Bachem's work in this space sits alongside its much older peptide business, which lets the company pitch itself as a single source for two major therapeutic modalities.
- Custom synthesis: small research batches built to a client's exact sequence.
- Process development: tuning coupling, purification, and yield so results repeat at larger scale.
- GMP manufacturing: clinical and commercial batches produced under current Good Manufacturing Practice.
- Analytical support: identity, purity, and impurity testing packaged with release documentation.
Bachem is a contract manufacturer, not a consumer supplement brand, and its oligonucleotide output goes to companies that hold or are pursuing the underlying regulatory filings. Capacity expansions and site investments are generally summarized in each bachem press release the company publishes.
How Oligonucleotide Synthesis and Scale-Up Work
Most commercial oligonucleotides are assembled with solid-phase phosphoramidite chemistry. Each base is added in a repeating cycle of coupling, oxidation, and deprotection until the full sequence is complete.
Scale is the variable that changes everything. A 10-micromole research batch and a multi-kilogram GMP campaign use the same chemistry but very different equipment, controls, and cost structures.
- Synthesis on a solid support resin
- Cleavage and deprotection
- Purification by HPLC or ion-exchange chromatography
- Desalting, lyophilization, and QC release
Moving from one scale to the next is rarely a simple multiplier. Transferring a process into larger reactors often shifts yield, impurity profiles, and purification requirements, which is why tech transfer is one of the hardest parts of oligonucleotide manufacturing.
Research Grade vs. GMP Grade: What Actually Changes
| Attribute | Research grade | GMP grade |
|---|---|---|
| Typical use | Screening, assay development | Clinical trials, commercial drugs |
| Documentation | Certificate of analysis | Batch records, deviations, stability data |
| Quality system | Standard internal QC | ICH Q7 / Q10-aligned, audited |
| Scale | Milligrams to grams | Grams to kilograms and beyond |
| Cost | Lower per project | Higher, driven by controls and release testing |
GMP-grade oligonucleotides require documented manufacturing controls that research-grade material does not, and that gap drives most of the price difference between the two categories.
Quality Control and Regulatory Documentation
Oligonucleotide QC focuses on the failure modes that are specific to synthesis: truncated sequences, residual solvents, and incomplete deprotection.
- Mass spectrometry for molecular weight confirmation
- Anion-exchange or reverse-phase HPLC for purity and impurity profiling
- Sequencing or enzymatic digestion for sequence verification
- Residual solvent, elemental impurity, and microbial testing
- Stability studies that support shelf-life claims
Oligonucleotide drugs still require FDA or EMA approval before they can be sold as medicines, so a manufacturer's GMP certificate is one step in that process rather than a substitute for it. Buyers should confirm which regulatory filings a supplier can support and whether the site has been inspected by a recognized authority.
Comparing Supplier Options for Oligonucleotide Programs
| Supplier type | Best fit for | Typical limits |
|---|---|---|
| Large integrated CDMO (Bachem-type) | Programs needing peptides and oligonucleotides under one quality system | Higher minimum order sizes; longer onboarding |
| Specialized oligonucleotide CDMO | Deep oligo chemistry and rapid sequence iteration | May not cover peptide APIs |
| Academic core facility | Early research and screening work | No GMP supply; limited scale |
| Research chemical vendor | Bench experiments labeled research use only | No regulatory documentation; not for human use |
The right choice depends on your phase. Early discovery rarely needs GMP, while a Phase III program cannot use anything else.
Bachem's Broader Portfolio and Why It Matters
Bachem started in peptides, and that history matters when you are sourcing oligonucleotides. The company's building-block catalog covers bachem amino acids, protected derivatives, and resins used in peptide synthesis, plus custom and catalog peptides.
A supplier that can handle peptides, oligonucleotides, and the raw materials behind both can simplify tech transfer and cut the number of vendors a program manager has to coordinate.
What to Ask Before You Place an Order
- What scale can you run today, and what is the quoted lead time?
- Which grade do you need now, and will it change across phases?
- Can you support my regulatory filing with a DMF or equivalent documentation?
- What is the plan if we scale up or transfer to another site?
- How are deviations, out-of-spec results, and change controls handled?
Consumer Peptide Questions vs. Manufacturing Reality
Search traffic around peptides often blends two very different worlds. On one side are contract services like Bachem oligonucleotide production. On the other are consumer listings, where a peptide sciences discount code sits next to vials labeled for laboratory research. Those listings are not pharmaceutical supply chains, and the material they sell is not intended for human consumption.
Approved peptide drugs show how the pipeline connects to patients. Bremelanotide, originally studied as PT-141, is the active ingredient in an FDA-approved product, and people evaluating it frequently search for vyleesi side effects before speaking with a prescriber. Questions such as pt-141 how long does it take to work belong with a licensed healthcare professional, not with a contract manufacturer.
Nothing here is medical advice. If you are considering any peptide-based treatment, talk to a licensed healthcare professional, and treat research-grade material as not for human use.
Frequently Asked Questions
What does Bachem do with oligonucleotides?
Bachem synthesizes and manufactures oligonucleotides as a contract development and manufacturing organization. Its services range from custom research-grade synthesis to GMP production for clinical and commercial programs. Bachem supplies pharmaceutical and biotech companies, not individual consumers.
Can I buy oligonucleotides from Bachem for personal use?
No. Bachem sells to pharmaceutical, biotech, and research organizations under commercial contracts, and its oligonucleotide material is not a consumer product. Products marketed directly to individuals are usually research chemicals labeled for laboratory use only. They are not the same as GMP pharmaceutical supply.
How long does a custom oligonucleotide order take from a CDMO?
Timelines depend on sequence length, chemical modifications, purification needs, and grade. Research-scale orders often ship within a few weeks, while GMP campaigns can take several months or longer because of process development, validation, and release testing. Confirm lead times in writing before committing to a program schedule.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.